Ascendis Pharma, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$13.6M
Doctors Paid
2,551
Transactions
11,782
2024 Total
$4.2M
Payment Breakdown by Category
Research$11.1M (82.2%)
Consulting$417,251 (3.1%)
Travel$293,413 (2.2%)
Food & Beverage$239,513 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $11.1M | 3,260 | 82.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.5M | 577 | 10.8% |
| Consulting Fee | $417,251 | 145 | 3.1% |
| Travel and Lodging | $293,413 | 1,100 | 2.2% |
| Food and Beverage | $239,513 | 6,664 | 1.8% |
| Education | $367.36 | 36 | 0.0% |
Payments by Type
Research
$11.1M
3,260 transactions
General
$2.4M
8,522 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| foresiGHt | $2.5M | 0 | 274 |
| New InsiGHts | $1.7M | 0 | 703 |
| enliGHten | $1.6M | 0 | 510 |
| foresiGHt extension | $1.0M | 0 | 136 |
| PaTH Forward | $863,837 | 0 | 179 |
| ApproaCH | $742,970 | 0 | 54 |
| PaTHway TRIAL | $694,652 | 1 | 107 |
| EAP of Palopegteriparatide in Patients With Hypoparathyroidism | $566,781 | 0 | 1,064 |
| SkybriGHt | $552,858 | 1 | 83 |
| SkyPASS | $540,885 | 1 | 81 |
| PaTHway | $204,267 | 0 | 54 |
| Emerald | $117,310 | 0 | 7 |
| IL Believe: A Phase 1/2, Open-label, Dose Escalation and Dose Expansion Study to Investigate the Safety and Tolerability of TransCon IL-2 / Alone or in Combination with Pembrolizumab or Standard of Care Chemotherapy in Participants Aged 18 Years or Older with Locally Advanced or Metastatic Solid Tumor Malignancies | $52,838 | 0 | 7 |
| BelieveIT-201 | $34,710 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Aristides Maniatis, Md, MD | Pediatric Endocrinology | Centennial, CO | $199,578 | $0 |
| Philippe Backeljauw, M.d, M.D | Pediatric Endocrinology | Cincinnati, OH | $158,133 | $0 |
| Dr. Joshua Yang, Md, MD | Pediatric Endocrinology | Orlando, FL | $140,804 | $0 |
| Dr. John Bilezikian, M.d, M.D | Endocrinology, Diabetes & Metabolism | New York, NY | $127,109 | $0 |
| Toni Kim, Md, MD | Pediatric Endocrinology | Sandy Springs, GA | $116,224 | $0 |
| Kent Reifschneider, M.d, M.D | Pediatric Endocrinology | Norfolk, VA | $89,494 | $0 |
| Lynn Kohlmeier, M.d, M.D | Endocrinology, Diabetes & Metabolism | Spokane, WA | $77,642 | $0 |
| Dr. James Suliburk, M.d, M.D | Surgery | Houston, TX | $67,724 | $0 |
| Dr. Mishaela Rubin, M.d, M.D | Endocrinology, Diabetes & Metabolism | New York, NY | $51,460 | $0 |
| Dr. Gary Edelson, Md, MD | Endocrinology, Diabetes & Metabolism | Farmington Hills, MI | $50,286 | $0 |
| Alan Rogol | Pediatrics | Charlottesville, VA | $49,296 | $0 |
| Asheesh Dewan, M.d, M.D | Pediatric Endocrinology | Las Vegas, NV | $40,942 | $0 |
| Todd Frieze, Md, MD | Endocrinology, Diabetes & Metabolism | Durham, NC | $39,991 | $0 |
| Dr. Nidhi Gupta, M.d, M.D | Pediatric Endocrinology | Franklin, TN | $39,729 | $0 |
| Dr. Dolores Shoback, Md, MD | Internal Medicine | San Francisco, CA | $38,638 | $0 |
| Elena Christofides, Md, Face, MD, FACE | Endocrinology, Diabetes & Metabolism | Columbus, OH | $38,483 | $0 |
| Dr. Elise Brett, M.d, M.D | Endocrinology, Diabetes & Metabolism | New York, NY | $29,712 | $0 |
| Mark Warren, M.d, M.D | Endocrinology, Diabetes & Metabolism | Greenville, NC | $28,684 | $0 |
| Timothy Flannery, M.d, M.D | Pediatric Endocrinology | Orange, CA | $25,979 | $0 |
| Bradley Miller, M.d, M.D | Pediatrics | Minneapolis, MN | $25,741 | $0 |
| Lisa Abbott, Md, MD | Endocrinology, Diabetes & Metabolism | Reno, NV | $24,064 | $0 |
| Dr. Eileen Baez Irizarry, M.d, M.D | Hospitalist | Phoenix, AZ | $23,496 | $0 |
| Dr. Erin Castelloe, M.d, M.D | Family Medicine | San Diego, CA | $23,156 | $0 |
| Tamara Vokes | Endocrinology, Diabetes & Metabolism | Chicago, IL | $21,957 | $0 |
| Deva Boone, Md, MD | Surgery | Scottsdale, AZ | $21,713 | $0 |
About Ascendis Pharma, Inc.
Ascendis Pharma, Inc. has made $13.6M in payments to 2,551 healthcare providers, recorded across 11,782 transactions in the CMS Open Payments database. In 2024, the company paid $4.2M. The top product by payment volume is SKYTROFA ($5.8M).
Payments were distributed across 82 medical specialties. The top specialty by payment amount is Pediatric Endocrinology ($996,259 to 291 doctors).
Payment categories include: Food & Beverage ($239,513), Consulting ($417,251), Research ($11.1M), Travel & Lodging ($293,413).
Ascendis Pharma, Inc. is associated with 3 products in the CMS Open Payments database.